AGENUS INC Payments of Ordinary Dividends, Preferred Stock and Preference Stock
AGENUS INC (AGEN) reported Payments of Ordinary Dividends, Preferred Stock and Preference Stock of $0 for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock · last filed 2017-03-16
- AGENUS INC payments of ordinary dividends, preferred stock and preference stock for the quarter ending 2014-12-31 was $0.00.
- AGENUS INC payments of ordinary dividends, preferred stock and preference stock for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- AGENUS INC payments of ordinary dividends, preferred stock and preference stock for the quarter ending 2013-09-30 was $0.00.
- AGENUS INC payments of ordinary dividends, preferred stock and preference stock for the quarter ending 2013-06-30 was $0.00.
- AGENUS INC payments of ordinary dividends, preferred stock and preference stock for fiscal 2014 was $460.96K.
- AGENUS INC payments of ordinary dividends, preferred stock and preference stock for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- AGENUS INC payments of ordinary dividends, preferred stock and preference stock for fiscal 2012 was $592.88K, a 25.00% decline from fiscal 2011.
- AGENUS INC payments of ordinary dividends, preferred stock and preference stock for fiscal 2011 was $790.50K, a 0.00% change from fiscal 2010.
| Period end | Payments of Ordinary Dividends, Preferred Stock and Preference Stock 3 month | Payments of Ordinary Dividends, Preferred Stock and Preference Stock 3 month as first filed | Payments of Ordinary Dividends, Preferred Stock and Preference Stock 6 month | Payments of Ordinary Dividends, Preferred Stock and Preference Stock 6 month as first filed | Payments of Ordinary Dividends, Preferred Stock and Preference Stock 9 month | Payments of Ordinary Dividends, Preferred Stock and Preference Stock 9 month as first filed | Payments of Ordinary Dividends, Preferred Stock and Preference Stock 12 month |
|---|---|---|---|---|---|---|---|
| 2015-09-30 | $0.00 10-Q · filed 2015-11-04 | ||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $460.96K 10-K · filed 2017-03-16 | |||||
| 2014-09-30 | $460.96K 10-Q · filed 2015-11-04 | -$460.96K 10-Q · filed 2014-10-31 | |||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $0.00 derived: sum of 2 quarters · filed 2014-10-31 | $0.00 10-Q · filed 2014-10-31 | $1.19M derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | $1.19M derived: sum of 3 quarters · filed 2015-03-16 | $988.13K derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-10 | $1.19M derived: sum of 2 quarters · filed 2015-03-16 | $988.13K derived: sum of 3 quarters · filed 2015-03-16 | $790.50K derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2012-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $988.13K derived: sum of 2 quarters · filed 2015-03-16 | $790.50K derived: sum of 3 quarters · filed 2015-03-16 | $592.88K 10-K · filed 2015-03-16 | |||
| 2012-09-30 | -$197.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$395.25K derived: sum of 2 quarters · filed 2013-11-08 | -$592.88K 10-Q · filed 2013-11-08 | $592.88K 10-Q · filed 2012-11-07 | -$395.25K derived: sum of 4 quarters · filed 2014-03-07 | ||
| 2012-06-30 | -$197.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$395.25K 10-Q · filed 2013-08-09 | $395.25K 10-Q · filed 2012-08-08 | -$197.63K derived: sum of 3 quarters · filed 2014-03-07 | $0.00 derived: sum of 4 quarters · filed 2014-03-07 | ||
| 2012-03-31 | -$197.63K 10-Q · filed 2013-05-10 | $197.63K 10-Q · filed 2012-05-09 | $0.00 derived: sum of 2 quarters · filed 2014-03-07 | $197.63K derived: sum of 3 quarters · filed 2014-03-07 | $395.25K derived: sum of 4 quarters · filed 2014-03-07 | ||
| 2011-12-31 | $197.63K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $395.25K derived: sum of 2 quarters · filed 2014-03-07 | $592.88K derived: sum of 3 quarters · filed 2014-03-07 | $790.50K 10-K · filed 2014-03-07 | |||
| 2011-09-30 | $197.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $395.25K derived: sum of 2 quarters · filed 2012-11-07 | $592.88K 10-Q · filed 2012-11-07 | $790.50K derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-06-30 | $197.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $395.25K 10-Q · filed 2012-08-08 | $592.88K derived: sum of 3 quarters · filed 2013-03-18 | $790.50K derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-03-31 | $197.63K 10-Q · filed 2012-05-09 | $395.25K derived: sum of 2 quarters · filed 2013-03-18 | $592.88K derived: sum of 3 quarters · filed 2013-03-18 | ||||
| 2010-12-31 | $197.63K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $395.25K derived: sum of 2 quarters · filed 2013-03-18 | $790.50K 10-K · filed 2013-03-18 | ||||
| 2010-09-30 | $197.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $592.88K 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $395.25K 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $790.50K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |